No evidence of an effect of alterations in dietary fatty acids on fasting adiponectin over 3 weeks

Obesity

Volumn 16, Issue 3, 2008, Pages 592-599

  Lithander, Fiona E ^a,b   Keogh, Geraldine F ^a,b   Wang, Yu ^b   Cooper, Garth J S ^a,b   Mulvey, Tom B ^b   Chan, Yih Kai ^a,b   McArdle, Brian H ^a   Poppitt, Sally D ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 40149106452     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.97     Document Type: Article

References (73)

1. 1 Spranger J., Kroke A., Möhlig M. et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003 ; 361: 226–228.
2. 2 Hotta K., Funahashi T., Arita Y. et al. Plasma concentrations of a novel, adipose‐specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000 ; 20: 1595–1599.
3. 3 Hu E., Liang P., Spiegelman BM. AdipoQ is a novel adipose‐specific gene dysregulated in obesity. J Biol Chem 1996 ; 271: 10697–10703.
4. 4 Arita Y., Kihara S., Ouchi N. et al. Paradoxical decrease of an adipose‐specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999 ; 257: 79–83.
5. 5 Asayama K., Hayashibe H., Dobashi K. et al. Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. Obes Res 2003 ; 11: 1072–1079.
6. 6 Matsubara M., Maruoka S., Katayose S.. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 2002 ; 87: 2764–2769.
7. 7 Nadler ST, Stoehr JP, Schueler KL et al. The expression of adipogenic genes is decreased in obesity and diabetes mellitus. Proc Natl Acad Sci USA 2000 ; 97: 11371–11376.
8. 8 Pellmé F., Smith U., Funahashi T. et al. Circulating adiponectin levels are reduced in nonobese but insulin‐resistant first‐degree relatives of type 2 diabetic patients. Diabetes 2003 ; 52: 1182–1186.
9. 9 Lihn AS, Bruun JM, He G. et al. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 2004 ; 219: 9–15.
10. 10 Fruebis J., Tsao TS, Javorschi S. et al. Proteolytic cleavage product of 30‐kDa adipocyte complement‐related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001 ; 98: 2005–2010.
11. 11 Yamauchi T., Kamon J., Waki H. et al. The fat‐derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001 ; 7: 941–946.
12. 12 Grundy SM, Vega GL. Plasma cholesterol responsiveness to saturated fatty acids. Am J Clin Nutr 1988 ; 47: 822–824.
13. 13 Grundy SM, Denke MA. Dietary influences on serum lipids and lipoproteins. J Lipid Res 1990 ; 31: 1149–1172.
14. 14 Lindstrom J., Eriksson JG, Valle TT et al. Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study: results from a randomized clinical trial. J Am Soc Nephrol 2003 ; 14: S108–S113.
15. 15 English PJ, Coughlin SR, Hayden K., Malik IA, Wilding JP. Plasma adiponectin increases postprandially in obese, but not in lean, subjects. Obes Res 2003 ; 11: 839–844.
16. 16 Esposito K., Nappo F., Giugliano F. et al. Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. Am J Clin Nutr 2003 ; 78: 1135–1140.
17. 17 Poppitt SD, Keogh GF, Leahy FE et al. Postprandial effects of lipid loading and fatty acid saturation on the adipose‐derived cardioprotective peptide adiponectin and pro‐inflammatory mediators IL‐6, TNF‐α and CRP. Nutrition, in press.
18. 18 Peake PW, Kriketos AD, Denyer GS, Campbell LV, Charlesworth JA. The postprandial response of adiponectin to a high‐fat meal in normal and insulin‐resistant subjects. Int J Obes Relat Metab Disord 2003 ; 27: 657–662.
19. 19 Karlsson FA, Engstrom BE, Lind L., Ohrvall M.. No postprandial increase of plasma adiponectin in obese subjects. Obes Res 2004 ; 12: 1032–1034.
20. 20 Berk ES, Kovera AJ, Boozer CN et al. Adiponectin levels during low‐ and high‐fat eucaloric diets in lean and obese women. Obes Res 2005 ; 13: 1566–1571.
21. 21 Bonnet F., Guebre‐Egziabher F., Rabasa R. et al. Impact of an enrichment of the diet in omega‐3 fatty acids on glucose metabolism and plasma adiponectin [abstr]. Obes Rev 2005 ; 6: 75.
22. 22 Hauner H., Petruschke T., Russ M., Röhrig K., Eckel J.. Effects of tumour necrosis factor alpha (TNF alpha) on glucose transport and lipid metabolism of newly‐differentiated human fat cells in cell culture. Diabetologia 1995 ; 38: 764–771.
23. 23 Ritchie DG. Interleukin 6 stimulates hepatic glucose release from prelabeled glycogen pools. Am J Physiol 1990 ; 258: E57–E64.
24. 24 Kelley DS. Modulation of human immune and inflammatory responses by dietary fatty acids. Nutrition 2001 ; 17: 669–673.
25. 25 Endres S., Ghorbani R., Kelley VE et al. The effect of dietary supplementation with n‐3 polyunsaturated fatty acids on the synthesis of interleukin‐1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989 ; 320: 265–271.
26. 26 Caughey GE, Mantzioris E., Gibson RA, Cleland LG, James MJ. The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n‐3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996 ; 63: 116–122.
27. 27 Thies F., Nebe‐von‐Caron G., Powell JR et al. Dietary supplementation with gamma‐linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans. J Nutr 2001 ; 131: 1918–1927.
28. 28 Rallidis LS, Paschos G., Liakos GK et al. Dietary alpha‐linolenic acid decreases C‐reactive protein, serum amyloid A and interleukin‐6 in dyslipidaemic patients. Atherosclerosis 2003 ; 167: 237–242.
29. 29 Baer DJ, Judd JT, Clevidence BA, Tracy RP. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr 2004 ; 79: 969–973.
30. 30 Jenkins DJ, Kendall CW, Marchie A. et al. Effects of a dietary portfolio of cholesterol‐lowering foods vs lovastatin on serum lipids and C‐reactive protein. JAMA 2003 ; 290: 502–510.
31. 31 Esposito K., Marfella R., Ciotola M. et al. Effect of a mediterranean‐style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004 ; 292: 1440–1446.
32. 32 Mezzano D.. Distinctive effects of red wine and diet on haemostatic cardiovascular risk factors. Biol Res 2004 ; 37: 217–224.
33. 33 Havel PJ, Kasim‐Karakas S., Mueller W. et al. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab 1996 ; 81: 4406–4413.
34. 34 Weigle DS, Duell PB, Connor WE et al. Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels. J Clin Endocrinol Metab 1997 ; 82: 561–565.
35. 35 Poppitt SD, Keogh GF, Mulvey TB et al. Lipid‐lowering effects of a modified butter‐fat: a controlled intervention trial in healthy men. Eur J Clin Nutr 2002 ; 56: 64–71.
36. 36 McDonald BE, Gerrard JM, Bruce VM, Corner EJ. Comparison of the effect of canola oil and sunflower oil on plasma lipids and lipoproteins and on in vivo thromboxane A2 and prostacyclin production in healthy young men. Am J Clin Nutr 1989 ; 50: 1382–1388.
37. 37 Schofield WN. Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr 1985 ; 39 (suppl 1): 5–41.
38. 38 Bingham SA, Cummings JH. Urine nitrogen as an independent validatory measure of dietary intake: a study of nitrogen balance in individuals consuming their normal diet. Am J Clin Nutr 1985 ; 42: 1276–1289.
39. 39 Johansson G., Callmer E., Gustafsson JA. Changing from a mixed meal diet to a Scandanavian vegetarian diet: effects on nutrient intake, food choice, meal pattern and cooking methods. Eur J Clin Nutr 1992 ; 46: 707–716.
40. 40 Bingham S., Cummings JH. The use of 4‐aminobenzoic acid as a marker to validate the completeness of 24 h urine collections in man. Clin Sci 1983 ; 64: 629–635.
41. 41 Pajvani UB, Du X., Combs TP et al. Structure‐function studies of the adipocyte‐secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem 2003 ; 278: 9073–9085.
42. 42 Patel SD, Rajala MW, Rossetti L., Scherer PE, Shapiro L.. Disulfide‐dependent multimeric assembly of resistin family hormones. Science 2004 ; 304: 1154–1158.
43. 43 Tsao TS, Murrey HE, Hug C., Lee DH, Lodish HF. Oligomerization state‐dependent activation of NF‐kappa B signaling pathway by adipocyte complement‐related protein of 30 kDa (Acrp30). J Biol Chem 2002 ; 277: 29359–29362.
44. 44 Waki H., Yamauchi T., Kamon J. et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 2003 ; 278: 40352–40363.
45. 45 Tsao TS, Lodish HF, Fruebis J.. ACRP30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacol 2002 ; 440: 213–221.
46. 46 Pajvani UB, Hawkins M., Combs TP et al. Complex distribution, not polute amount of adiponectin, correlates with thiazolidinedione‐mediated improvement in insulin sensitivity. J Biol Chem 2004 ; 279: 12152–12162.
47. 47 Kobayashi H., Ouchi N., Kihara S. et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 2004 ; 94: e27–e31.
48. 48 Pischon T., Girman CJ, Rifai N., Hotamisligil GS, Rimm EB. Association between dietary factors and plasma adiponectin concentrations in men. Am J Clin Nutr 2005 ; 81: 780–786.
49. 49 Yannakoulia M., Yiannakouris N., Bluher S. et al. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab 2003 ; 88: 1730–1736.
50. 50 Livingstone MB, Prentice AM, Strain JJ et al. Accuracy of weighed dietary records in studies of diet and health. Br Med J 1990 ; 300: 708–712.
51. 51 Livingstone MBE, Davies PSW, Prentice AM et al. Comparison of simultaneous measures of energy intake and expenditure in children and adolescents. Proc Nutr Soc 1991 ; 50: 15a.
52. 52 Black AE, Jebb SA, Bingham SA. Validation of energy and protein intake assessed by diet history and weighed record against energy expenditure and 24‐hour urinary nitrogen excretion. Proc Nutr Soc 1991 ; 50: 108A.
53. 53 Imbeault P., Pomerleau M., Harper ME, Doucet E.. Unchanged fasting and postprandial adiponectin levels following a 4‐day caloric restriction in young healthy men. Clin Endocrinol (Oxf) 2004 ; 60: 429–433.
54. 54 Weyer C., Funahashi T., Tanaka S. et al. Hypoadiponectima in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001 ; 86: 1930–1935.
55. 55 Yang WS, Lee WJ, Funahashi T. et al. Weight reduction increases plasma levels of an adipose‐derived anti‐inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001 ; 86: 3815–3819.
56. 56 Kern PA, Di Gregorio GB, Lu T., Rassouli N., Ranganathan G.. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor‐alpha expression. Diabetes 2003 ; 52: 1779–1785.
57. 57 Fasshauer M., Kralisch S., Klier M. et al. Adiponectin gene expression and secretion is inhibited by interleukin‐6 in 3T3‐L1 adipocytes. Biochem Biophys Res Commun 2003 ; 301: 1045–1050.
58. 58 Ros E.. Dietary cis‐monounsaturated fatty acids and metabolic control in type 2 diabetes. Am J Clin Nutr 2003 ; 78: 617S–625S.
59. 59 Lopez‐Garcia E., Schulze MB, Manson JE et al. Consumption of (n‐3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004 ; 134: 1806–1811.
60. 60 Heilbronn LK, Noakes M., Clifton PM. Energy restriction and weight loss on very‐low‐fat diets reduce C‐reactive protein concentrations in obese, healthy women. Arterioscler Thromb Vasc Biol 2001 ; 21: 968–970.
61. 61 Mattusch F., Dufaux B., Heine O., Mertens I., Rost R.. Reduction of the plasma concentration of C‐reactive protein following nine months of endurance training. Int J Sports Med 2000 ; 21: 21–24.
62. 62 Ford ES. Does exercise reduce inflammation? Physical activity and C‐reactive protein among U.S. adults. Epidemiology 2002 ; 13: 561–568.
63. 63 Smith JK, Dykes R., Douglas JE, Krishnaswamy G., Berk S.. Long‐term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA 1999 ; 281: 1722–1727.
64. 64 Havel PJ, Townsend R., Chaump L., Teff K.. High‐fat meals reduce 24‐h circulating leptin concentrations in women. Diabetes 1999 ; 48: 334–341.
65. 65 Sinha MK, Ohannesian JP, Heiman ML et al. Nocturnal rise of leptin in lean, obese, and non‐insulin‐dependent diabetes mellitus subjects. J Clin Invest 1996 ; 97: 1344–1347.
66. 66 Laughlin GA, Yen SS. Hypoleptinemia in women athletes: absence of a diurnal rhythm with amenorrhea. J Clin Endocrinol Metab 1997 ; 82: 318–321.
67. 67 Saad MF, Riad‐Gabriel MG, Khan A. et al. Diurnal and ultradian rhythmicity of plasma leptin: effects of gender and adiposity. J Clin Endocrinol Metab 1998 ; 83: 453–459.
68. 68 Peeters TL. Ghrelin: a new player in the control of gastrointestinal functions. Gut 2005 ; 54: 1638–1649.
69. 69 Tschöp M., Wawarta R., Riepl RL et al. Post‐prandial decrease of circulating human ghrelin levels. J Endocrinol Invest 2001 ; 24: RC19–21.
70. 70 Shiiya T., Nakanzato M., Mizuta M. et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 2002 ; 87: 240–244.
71. 71 Monteleone P., Bencivenga R., Longobardi N., Serritella C., Maj M.. Differential responses of circulating ghrelin to high‐fat or high‐carbohydrate meal in healthy women. J Clin Endocrinol Metab 2003 ; 88: 5510–5514.
72. 72 Greenman Y., Golani N., Gilad S. et al. Ghrelin secretion is modulated in a nutrient‐ and gender‐specific manner. Clin Endocrinol (Oxf) 2004 ; 60: 382–388.
73. 73 Erdmann J., Töpsch R., Lippl F., Gussmann P., Schusdziarra V.. Postprandial response of plasma ghrelin levels to various test meals in relation to food intake, plasma insulin, and glucose. J Clin Endocrinol Metab 2004 ; 89: 3048–3054.